Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK

British National Formulary

Journal of the American Pharmaceutical Association (Scientific ed ) · 1958 · 2.5K citations

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

Medicine, Ophthalmology, Pharmacology +11

The Five-year Incidence and Progression of Age-related Maculopathy

Ronald Klein, Susan C. Jensen, Stacy M. Meuer · Ophthalmology · 1997 · 1.1K citations

Medicine, Pathology, Aging +12

PHARMACEUTICAL SOCIETY OF GREAT BRITAIN.

ArthurW. Hill · The Lancet · 1930 · 378 citations

Pharmacy, Pharmaceutical Policy, Pharmaceutical Regulation +1

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study1 1The authors have no proprietary interest in the products or devices mentioned herein.

Ronald Klein, Sandra C. Tomany, Stacy M. Meuer et al. · Ophthalmology · 2002 · 359 citations

Medicine, Ophthalmology, Ocular Disease +15